Ginkgo Bioworks Holdings, Inc.DNANYSE
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank22
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P22
Within normal range
vs 2Y Ago
-2.4x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-50.85%
Q3 202521.48%
Q2 202521.87%
Q1 2025-21.41%
Q4 202459.00%
Q3 2024-22.65%
Q2 20245.45%
Q1 2024-54.34%
Q4 202321.37%
Q3 2023-0.02%
Q2 202318.82%
Q1 202313.34%
Q4 2022-267.14%
Q3 202271.33%
Q2 2022-399.03%
Q1 202287.98%
Q4 2021-3062.20%
Q3 202185.00%
Q2 202127.47%
Q1 202118.89%
Q4 2020-134.82%
Q3 20207.13%
Q2 2020-13.31%
Q1 20200.00%